إعلان
إعلان
VKTX
Viking Therapeutics, Inc
35.40
USDبرعاية
+0.22
+0.63%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
35.28
-0.12
-0.34%
تقارير أرباح VKTX
النسبة الإيجابية المفاجئة
VKTX تفوق 22 من 40 آخر التقديرات.
55%
التقرير التالي
بيانات التقرير القادم
٠٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.90
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+11.11%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+181.25%
Viking Therapeutics, Inc earnings per share and revenue
On ٢٢ أكتوبر ٢٠٢٥, VKTX reported earnings of -0.81 USD per share (EPS) for Q3 25, missing the estimate of -0.69 USD, resulting in a -17.20% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.96% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 19 analysts forecast an EPS of -0.90 USD, with revenue projected to reach -- USD, implying an increase of 11.11% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Viking Therapeutics, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Viking Therapeutics, Inc reported EPS of -$0.81, missing estimates by -17.2%, and revenue of $0.00, 0% as expectations.
How did the market react to Viking Therapeutics, Inc's Q3 2025 earnings?
The stock price moved up 7.96%, changed from $31.42 before the earnings release to $33.92 the day after.
When is Viking Therapeutics, Inc expected to report next?
The next earning report is scheduled for ٠٣ فبراير ٢٠٢٦.
What are the forecasts for Viking Therapeutics, Inc's next earnings report?
Based on 19
analysts, Viking Therapeutics, Inc is expected to report EPS of -$0.90 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان